monoctanoin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 3364 | 502-54-5 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
dissolution agent for retained cholesterol bile duct stones; RN in Chemline for octanoic acid, ester with 1,2,3-propanetriol, MF unknown: 11140-04-8; RN for octanoic acid, 2,3-dihydroxypropyl ester (1-monooctanoin): 502-54-5; RN in 9th CI Form Index for (+-)-1-monooctanoin: 19670-49-6
Legend: OFP - off patent OFM - off market ONP - on patent |
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Oct. 29, 1985 | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
None
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 13.62 | acidic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| 4021038 | VUID |
| N0000179197 | NUI |
| D05073 | KEGG_DRUG |
| 4021038 | VANDF |
| C0066770 | UMLSCUI |
| CHEBI:84309 | CHEBI |
| CHEMBL3301678 | ChEMBL_ID |
| CHEMBL3304484 | ChEMBL_ID |
| DB06801 | DRUGBANK_ID |
| 3033877 | PUBCHEM_CID |
| C025343 | MESH_SUPPLEMENTAL_RECORD_UI |
| VFU0OU98LO | UNII |
| 30198 | RXNORM |
| 1833 | MMSL |
| 7406 | MMSL |
| d01006 | MMSL |
| 001211 | NDDF |
| 010610 | NDDF |
| 108671000 | SNOMEDCT_US |
| 412545009 | SNOMEDCT_US |
Pharmaceutical products:
None